Mosaic ImmunoEngineering Inc. (CPMV) › Total AssetsMosaic ImmunoEngineering Inc. (CPMV) — Total AssetsAnnual figures by period end, from SEC filings.2011-05-31: $12.60M2012-05-31: $8.14M2013-05-31: $8.41M2014-05-31: $6.80M2015-05-31: $5.18M2016-05-31: $3.82M2017-05-31: $3.76M2018-05-31: $2.58M2019-05-31: $1.92M2020-05-31: $818.6K2020-12-31: $457.8K2021-12-31: $269.5K2022-12-31: $261.3K2023-12-31: $179.5K2024-12-31: $141.6K2025-12-31: $19.9K$19.9K2011-05-31Total Assets (USD)2025-12-31Period endedTotal AssetsChange YoYSource filing2025-12-31$19.9K-86.0%2026-04-15Balance as of period end2024-12-31$141.6K-21.1%2026-04-15Balance as of period end2023-12-31$179.5K-31.3%2025-04-15Balance as of period end2022-12-31$261.3K-3.0%2024-04-15Balance as of period end2021-12-31$269.5K-41.1%2023-03-02Balance as of period end2020-12-31$457.8K—2022-01-26Balance as of period end2020-05-31$818.6K-57.5%2020-08-24Balance as of period end2019-05-31$1.92M-25.4%2020-08-24Balance as of period end2018-05-31$2.58M-31.4%2019-08-29Balance as of period end2017-05-31$3.76M-1.6%2018-08-29Balance as of period end2016-05-31$3.82M-26.2%2017-08-29Balance as of period end2015-05-31$5.18M-23.8%2016-08-29Balance as of period end2014-05-31$6.80M-19.2%2015-08-31Balance as of period end2013-05-31$8.41M+3.4%2014-08-19Balance as of period end2012-05-31$8.14M-35.4%2013-08-23Balance as of period end2011-05-31$12.60M—2012-08-29Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)